ArticleCancers2025

Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group.

Maxwell Otiato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.